CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 18 filers reported holding CLEVELAND BIOLABS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $104,000 | +2500.0% | 19,007 | +2465.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 741 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 741 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 741 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 741 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 741 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 741 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -83.3% | 741 | -83.1% | 0.00% | – |
| Q2 2019 | $6,000 | -73.9% | 4,395 | -67.8% | 0.00% | – |
| Q1 2019 | $23,000 | +53.3% | 13,629 | -6.2% | 0.00% | – |
| Q4 2018 | $15,000 | -50.0% | 14,525 | -1.7% | 0.00% | – |
| Q3 2018 | $30,000 | -14.3% | 14,781 | +4.1% | 0.00% | – |
| Q2 2018 | $35,000 | 0.0% | 14,205 | +21.9% | 0.00% | – |
| Q1 2018 | $35,000 | -40.7% | 11,657 | -20.9% | 0.00% | – |
| Q4 2017 | $59,000 | +18.0% | 14,732 | +3.1% | 0.00% | – |
| Q3 2017 | $50,000 | +16.3% | 14,292 | -4.1% | 0.00% | – |
| Q2 2017 | $43,000 | +760.0% | 14,897 | +320.7% | 0.00% | – |
| Q1 2017 | $5,000 | – | 3,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 320,053 | $1,104,000 | 0.04% |
| Renaissance Technologies | 165,651 | $571,000 | 0.00% |
| VANGUARD GROUP INC | 52,592 | $181,000 | 0.00% |
| UBS Group AG | 4,812 | $17,000 | 0.00% |
| IFP Advisors, Inc | 150 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 15,000 | $52,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |